Edition:
United Kingdom

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

18.34USD
5:19pm GMT
Change (% chg)

$0.32 (+1.80%)
Prev Close
$18.02
Open
$18.00
Day's High
$18.40
Day's Low
$17.99
Volume
185,945
Avg. Vol
647,302
52-wk High
$22.38
52-wk Low
$5.36

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 34.66 0.130
FY 2018 Sep '18 11.26 -0.122
Jun '18 0.73 -0.178
Mar '18 0.65 -0.177
Dec 3.51 -0.176
FY 2017 Sep '17 8.71 -0.144
Jun '17 9.34 -0.074
Mar '17 8.99 -0.081
Dec 4.37 -0.169
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 3 17.03 21.10 10.00 --
Quarter Ending Mar-19 7 42.56 55.00 33.00 0.10
Year Ending Sep-19 7 194.51 229.66 133.66 10.48
Year Ending Sep-20 6 76.22 129.00 40.00 20.55
Earnings (per share)
Quarter Ending Dec-19 3 -0.08 -0.02 -0.18 --
Quarter Ending Mar-19 7 0.19 0.33 0.10 -0.22
Year Ending Sep-19 7 1.04 1.49 0.39 -0.80
Year Ending Sep-20 6 -0.24 0.26 -0.78 -0.85
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 1.91 1.08 0.90
Price to Sales (TTM) 13.98 49.51 6.29
Price to Book (MRQ) 3.53 10.14 5.26
Price to Tangible Book (MRQ) 4.59 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 20.93 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg 0.00 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 23,504.09 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago 13,202.80 48.79 5.84
Sales - 5 Yr. Growth Rate -11.77 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 77.21 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 52.78 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate 231.31 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 3.83 3.50 3.08
LT Debt to Equity (MRQ) 2.64 18.65 11.38
Total Debt to Equity (MRQ) 2.87 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -185.30 -- --
EBITD - 5 Yr. Avg -22,595.10 -110.41 12.87
Operating Margin (TTM) -213.60 -184.63 6.19
Operating Margin - 5 Yr. Avg. -24,149.16 -126.89 8.31
Pre-Tax Margin (TTM) -201.84 -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -24,832.79 -132.69 8.61
Net Profit Margin (TTM) -201.85 -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -24,833.66 -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,108 7,654,547 842,388,263
Net Income/Employee (TTM) -405,933 562,105 99,841,601
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.23 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.73 6.39 11.06
Return on Assets - 5 Yr. Avg. -64.90 5.47 12.20
Return on Investment (TTM) -55.08 8.92 14.45
Return on Investment - 5 Yr. Avg. -73.47 6.78 15.87
Return on Equity (TTM) -61.13 10.08 15.96
Return on Equity - 5 Yr. Avg. -77.24 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -58.55 -18.29 -11.77
EPS (TTM) % 16.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arrowhead Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 36.66 31.94 99 99
13 Week 162.35 149.57 99 95
26 Week 156.02 136.56 99 98
52 Week -39.54 -48.76 71 72
YTD 174.19 140.80 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.77%
# of Holders: 212
Total Shares Held: 60,080,750
3 Mo. Net Change: 3,243,132
# New Positions: 66
# Closed Positions: 32
# Increased Positions: 126
# Reduced Positions: 87
# Net Buyers: 39
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.